A detailed history of Putnam Investments LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 69,593 shares of AMRX stock, worth $607,546. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,593
Previous 152,621 54.4%
Holding current value
$607,546
Previous $644,000 34.47%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$3.36 - $6.21 $278,974 - $515,603
-83,028 Reduced 54.4%
69,593 $422,000
Q3 2023

Nov 14, 2023

BUY
$2.76 - $4.59 $421,233 - $700,530
152,621 New
152,621 $644,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.32B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.